Screening of Merck KGaA Mini Library for Leishmaniasis and Amoebiasis Drug Discovery

Status
On going
Start date
Start stage
Screening
Disease
Other - HIV, Chikungunya, Influenza, Zika
Leishmaniasis
Research areas
Drug

Merck KGaA, Darmstadt, Germany will be sharing its Mini Library of compounds with Prof. Fabrice Boyom at University of Yaoundé I for leishmaniasis and amoebiasis drug discovery. Merck KGaA, Darmstadt, Germany’s Mini Library is a collection of drug-like former Biopharma research and development compounds and their derivatives. The compounds cover a wide range of molecular targets, including enzymes, hormone and neurotransmitter receptors, transporters, and ion channels.